GlaxoSmithKline’s Two-Drug HIV Treatment As Effective As Standard Triple Therapy.

Reuters (7/24, Hirschler) reports GlaxoSmithKline experimental combination of dolutegravir and lamivudine to treat HIV “works as well as standard triple therapy, even in people with relatively high levels of the virus that causes AIDS, clinical study res...